Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in China

Background To determine the efficacy of low-dose, immediate-release tacrolimus in patients with myasthenia gravis (MG) with inadequate response to glucocorticoid therapy in a randomized, double-blind, placebo-controlled study. Methods Eligible patients had inadequate response to glucocorticoids (GCs...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Lei Zhou, Weibin Liu, Wei Li, Haifeng Li, Xu Zhang, Huifang Shang, Bitao Bu, Hui Deng, Qi Fang, Jimei Li, Hua Zhang, Zhi Song, Changyi Ou, Chuanzhu Yan, Tao Liu, Hongyu Zhou, Jianhong Bao, Jiahong Lu, Huawei Shi, Chongbo Zhao
Формат: Artigo
Язык:Inglês
Опубликовано: SAGE Publishing 2017-09-01
Серии:Therapeutic Advances in Neurological Disorders
Online-ссылка:https://doi.org/10.1177/1756285617721092
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы